Enhancing Education to Avoid Complications in Endovascular Treatment of Unruptured Intracranial Aneurysms: A Neurointerventionalist’s Perspective

M. Goyal; J. Fiehler; W. van Zwam; J.H. Wong; J.M. Ospel

doi:10.3174/ajnr.A6830

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

SUMMARY: It is of utmost importance to avoid errors and subsequent complications when performing neurointerventional procedures, particularly when treating low-risk conditions such as unruptured intracranial aneurysms. We used endovascular treatment of unruptured intracranial aneurysms as an example and took a survey-based approach in which we reached out to 233 neurointerventionalists. They were asked what they think are the most important points staff should teach their trainees to avoid errors and subsequent complications in endovascular treatment of unruptured intracranial aneurysms. One hundred twenty-one respondents (51.9%) provided answers in the form of free text responses, which were thematically clustered in an affinity diagram and summarized in this Practice Perspectives. The article is primarily intended for neurointerventional radiology fellows and junior staff and will hopefully provide them the opportunity to learn from the mistakes of their more experienced colleagues.

Footnotes

Disclosures: Mayank Goyal—RELATED: Consulting Fee or Honorarium: Mentice, Comments: advice on acute stroke intervention; UNRELATED: Consultancy: Stryker, Medtronic, MicroVention; Patents (Planned, Pending or Issued): GE Healthcare, Comments: licensing agreement for systems of acute stroke diagnosis. Jens Fiehler—UNRELATED: Consultancy: Acandis, Cerenovus, Medtronic, MicroVention, Stryker, Penumbra; Grants/Grants Pending: Acandis, Cerenovus, Medtronic, MicroVention, Stryker, Route94*; Stock/Stock Options: Tegus; OTHER RELATIONSHIPS: CEO Eppdata. Wim van Zwam—UNRELATED: Payment for Lectures Including Service on Speakers Bureaus: Cerenovus, Stryker,* John H. Wong—UNRELATED: Stock/Stock Options: Fluid Biotech Inc, Comments: Cofounder and CEO of Fluid Biotech Inc. Johanna M. Ospel—UNRELATED: Grants/Grants Pending: Gottfried und Julia Bangerter Rhyner Stiftung, University of Basel Research Foundation, Freiwiliige Akademische Gesellschaft Basel, Comments: research scholarships. *Money paid to the institution.